Cytra-3 and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Cytra-3 and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / potassium citrate / sodium citrate
Brand name: Cytra-3, Polycitra, Polycitra-LC, Tricitrates, Virtrate-3
Synonyms: Cytra-3 Oral Syrup
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cytra-3-Insulin glargine, recombinant Subcutaneous
- Cytra-3-Insulin glulisine
- Cytra-3-Insulin Glulisine (Cartridges and Pens)
- Cytra-3-Insulin Glulisine (Vials)
- Cytra-3-Insulin glulisine Subcutaneous
- Cytra-3-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Cytra-3 Oral Syrup
- Insulin glargine and lixisenatide Subcutaneous-Cytra-K
- Insulin glargine and lixisenatide Subcutaneous-Cytra-K (Potassium Citrate and Citric Acid Powder Pack)
- Insulin glargine and lixisenatide Subcutaneous-Cytra-K (Potassium Citrate and Citric Acid Solution)